Literature DB >> 29045138

Importance of the C-Terminus of Aldehyde Dehydrogenase 7A1 for Oligomerization and Catalytic Activity.

David A Korasick1, Jesse W Wyatt2, Min Luo2, Adrian R Laciak2, Kasi Ruddraraju2, Kent S Gates1,2, Michael T Henzl1, John J Tanner1,2.   

Abstract

Aldehyde dehydrogenase 7A1 (ALDH7A1) catalyzes the terminal step of lysine catabolism, the NAD+-dependent oxidation of α-aminoadipate semialdehyde to α-aminoadipate. Structures of ALDH7A1 reveal the C-terminus is a gate that opens and closes in response to the binding of α-aminoadipate. In the closed state, the C-terminus of one protomer stabilizes the active site of the neighboring protomer in the dimer-of-dimers tetramer. Specifically, Ala505 and Gln506 interact with the conserved aldehyde anchor loop structure in the closed state. The apparent involvement of these residues in catalysis is significant because they are replaced by Pro505 and Lys506 in a genetic deletion (c.1512delG) that causes pyridoxine-dependent epilepsy. Inspired by the c.1512delG defect, we generated variant proteins harboring either A505P, Q506K, or both mutations (A505P/Q506K). Additionally, a C-terminal truncation mutant lacking the last eight residues was prepared. The catalytic behaviors of the variants were examined in steady-state kinetic assays, and their quaternary structures were examined by analytical ultracentrifugation. The mutant enzymes exhibit a profound kinetic defect characterized by markedly elevated Michaelis constants for α-aminoadipate semialdehyde, suggesting that the mutated residues are important for substrate binding. Furthermore, analyses of the in-solution oligomeric states revealed that the mutant enzymes are defective in tetramer formation. Overall, these results suggest that the C-terminus of ALDH7A1 is crucial for the maintenance of both the oligomeric state and the catalytic activity.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29045138      PMCID: PMC5928510          DOI: 10.1021/acs.biochem.7b00803

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  21 in total

1.  Impact of disease-Linked mutations targeting the oligomerization interfaces of aldehyde dehydrogenase 7A1.

Authors:  David A Korasick; John J Tanner; Michael T Henzl
Journal:  Chem Biol Interact       Date:  2017-01-10       Impact factor: 5.192

2.  Global rigid body modeling of macromolecular complexes against small-angle scattering data.

Authors:  Maxim V Petoukhov; Dmitri I Svergun
Journal:  Biophys J       Date:  2005-05-27       Impact factor: 4.033

3.  ALAD porphyria is a conformational disease.

Authors:  Eileen K Jaffe; Linda Stith
Journal:  Am J Hum Genet       Date:  2006-12-21       Impact factor: 11.025

4.  Chemical synthesis of allysine ethylene acetal and conversion in situ into 1-piperideine-6-carboxylic acid: key intermediate of the alpha-aminoadipic acid for beta-lactam antibiotics biosynthesis.

Authors:  A Rumbero; J F Martín; M A Lumbreras; P Liras; C Esmahan
Journal:  Bioorg Med Chem       Date:  1995-09       Impact factor: 3.641

5.  Environmental contaminants perturb fragile protein assemblies and inhibit normal protein function.

Authors:  Sarah H Lawrence; Trevor Selwood; Eileen K Jaffe
Journal:  Curr Chem Biol       Date:  2013

Review 6.  Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application.

Authors:  Vindhya Koppaka; David C Thompson; Ying Chen; Manuel Ellermann; Kyriacos C Nicolaou; Risto O Juvonen; Dennis Petersen; Richard A Deitrich; Thomas D Hurley; Vasilis Vasiliou
Journal:  Pharmacol Rev       Date:  2012-04-27       Impact factor: 25.468

7.  FoXS: a web server for rapid computation and fitting of SAXS profiles.

Authors:  Dina Schneidman-Duhovny; Michal Hammel; Andrej Sali
Journal:  Nucleic Acids Res       Date:  2010-05-27       Impact factor: 16.971

Review 8.  Pyridoxine-Dependent Epilepsy: An Expanding Clinical Spectrum.

Authors:  Clara D M van Karnebeek; Sylvia A Tiebout; Jikkemien Niermeijer; Bwee Tien Poll-The; Aisha Ghani; Curtis R Coughlin; Johan L K Van Hove; Jost Wigand Richter; Hans Juergen Christen; Renata Gallagher; Hans Hartmann; Sylvia Stockler-Ipsiroglu
Journal:  Pediatr Neurol       Date:  2016-01-11       Impact factor: 3.372

9.  Robust, high-throughput solution structural analyses by small angle X-ray scattering (SAXS).

Authors:  Greg L Hura; Angeli L Menon; Michal Hammel; Robert P Rambo; Farris L Poole; Susan E Tsutakawa; Francis E Jenney; Scott Classen; Kenneth A Frankel; Robert C Hopkins; Sung-Jae Yang; Joseph W Scott; Bret D Dillard; Michael W W Adams; John A Tainer
Journal:  Nat Methods       Date:  2009-07-20       Impact factor: 28.547

10.  Structural Basis of Substrate Recognition by Aldehyde Dehydrogenase 7A1.

Authors:  Min Luo; John J Tanner
Journal:  Biochemistry       Date:  2015-08-19       Impact factor: 3.162

View more
  4 in total

1.  Structural and biochemical consequences of pyridoxine-dependent epilepsy mutations that target the aldehyde binding site of aldehyde dehydrogenase ALDH7A1.

Authors:  Adrian R Laciak; David A Korasick; Jesse W Wyatt; Kent S Gates; John J Tanner
Journal:  FEBS J       Date:  2019-07-25       Impact factor: 5.542

2.  NAD+ promotes assembly of the active tetramer of aldehyde dehydrogenase 7A1.

Authors:  David A Korasick; Tommi A White; Srinivas Chakravarthy; John J Tanner
Journal:  FEBS Lett       Date:  2018-09-18       Impact factor: 4.124

3.  Structural analysis of pathogenic mutations targeting Glu427 of ALDH7A1, the hot spot residue of pyridoxine-dependent epilepsy.

Authors:  Adrian R Laciak; David A Korasick; Kent S Gates; John J Tanner
Journal:  J Inherit Metab Dis       Date:  2019-12-01       Impact factor: 4.982

Review 4.  Impact of missense mutations in the ALDH7A1 gene on enzyme structure and catalytic function.

Authors:  David A Korasick; John J Tanner
Journal:  Biochimie       Date:  2020-09-19       Impact factor: 4.079

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.